Esculentoside A
Esculentoside A can suppress inflammatory responses in LPS-induced ALI through inhibition of the NF-κB and mitogen-activated protein kinase signaling pathways. Esculentoside A may be useful for the treatment of autoimmune disease through modulation on T cell-mediated adaptive immunity. Esculentoside A may play significant roles in the treatment of BXSB mice through modulation of inflammatory cytokines, inhibition of renal cell proliferation and induction of apoptosis.
| Catalog Number | T3877 |
| Research Area | Neuroscience|||Immunology/Inflammation|||NF-Κb |
| Molecular Formula | C42H66O16 |
| CAS# | 65497-07-6 |
| Purity | 99.81% |
| SMILES | [C@@H]1([C@H](C[C@]2([C@H]([C@@]1(CO)C)CC[C@@]1(C)[C@]3(C)CC[C@@]4(C(=O)O)CC[C@](C)(C(=O)OC)C[C@H]4C3=CC[C@H]21)C)O)O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@H](O2)CO)CO1 |
| Size | 1 mg |
| Supplier Page | https://www.targetmol.com/compound/Esculentoside A |
| Additional Information | https://www.targetmol.com/datasheet/T3877 |